tiprankstipranks
Trending News
More News >
Can-Fite BioPharma (CANF)
:CANF
US Market

Can-Fite BioPharma (CANF) Financial Statements

Compare
578 Followers

Can-Fite BioPharma Financial Overview

Can-Fite BioPharma's market cap is currently $14.06M. The company's EPS TTM is $; its P/E ratio is ―; Can-Fite BioPharma is scheduled to report earnings on May 22, 2025, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 674.00K$ 743.00K$ 810.00K$ 853.00K$ 763.00K
Gross Profit$ 674.00K$ 743.00K$ 810.00K$ 853.00K$ 763.00K
Operating Income$ -8.13M$ -8.20M$ -10.10M$ -12.84M$ -14.14M
EBITDA$ -8.12M$ -8.18M$ -10.08M$ -12.83M$ -14.13M
Net Income$ -7.88M$ -7.63M$ -10.53M$ -12.60M$ -14.81M
Balance Sheet
Cash & Short-Term Investments$ 7.89M$ 8.92M$ 7.98M$ 19.14M$ 8.34M
Total Assets$ 9.12M$ 9.99M$ 9.28M$ 20.25M$ 9.52M
Total Debt$ 104.00K$ 40.00K$ 62.00K$ 124.00K$ 67.00K
Net Debt$ -4.72M$ -4.24M$ -2.92M$ -4.27M$ -8.20M
Total Liabilities$ 3.68M$ 3.75M$ 4.81M$ 5.87M$ 3.45M
Stockholders' Equity$ 5.44M$ 6.24M$ 4.47M$ 14.38M$ 6.07M
Cash Flow
Free Cash Flow$ -7.64M$ -8.44M$ -10.81M$ -9.87M$ -12.09M
Operating Cash Flow$ -7.64M$ -8.44M$ -10.80M$ -9.86M$ -12.06M
Investing Cash Flow$ 1.50M$ 498.00K$ 9.50M$ -14.51M$ -26.00K
Financing Cash Flow$ 6.71M$ 9.14M$ 0.00$ 20.46M$ 17.68M
Currency in USD

Can-Fite BioPharma Earnings and Revenue History

Can-Fite BioPharma Debt to Assets

Can-Fite BioPharma Cash Flow

Can-Fite BioPharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis